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reflect differences in experimental 
conditions or divergence between 
cell line isolates. These are mitigated 
in our analysis by the use of positive 
controls (monastrol washout to 
induce lagging centrics and low dose 
aphidicolin to prevent efficient DNA 
replication and induce acentrics and 
bridges) and orthogonal methods 
(immunodetection of two centromere 
markers, and FISH using an all-
centromere probe) to confirm our 
ability to identify lagging centrics, 
acentrics and bridges, and by 
examination of multiple cell lines of a 
single cancer type (colorectal) [7].
These data raise an important 
point about controls for CIN+ versus 
CIN- comparisons. Our analysis of 
HCT116 and DLD1 lagging centrics 
and anaphase bridges is concordant 
with Bakhoum et al.’s data [1,7]. 
However, in three additional CIN- 
colorectal cancer cell lines we 
observed low percentages of bridges 
(similar to DLD1 cells), indicating 
that bridges are significantly more 
frequent in CIN+ than CIN- cells 
within our larger, tissue-type specific 
cell line panel. Bakhoum et al. 
use cell lines from multiple cancer 
types, making comparisons more 
difficult, since absolute segregation 
error frequencies may vary between 
CIN+ breast, cervical and colorectal 
cancers.
One conclusion of our study [7] 
was that replication stress can lead 
to deviation of centromere numbers 
determined by centromeric FISH. 
Importantly we demonstrated this 
deviation in cell clones grown for 
multiple generations following 
induction of replication stress 
by depletion of PIGN, ZNF516 or 
MEX3C, demonstrating ongoing 
change in centromere number as 
observed in CIN+ cells [1,6]. Our 
findings that a high proportion of 
chromosome segregation errors 
in CIN+ colorectal cancer cells are 
pre-mitotic in origin, combined with 
multiple additional experiments 
demonstrating elevated replication 
stress in CIN+ compared to CIN- 
colorectal cancer cell lines, led 
us to conclude that replication 
stress-induced chromosome 
missegregation is an important 
contributor to CIN in colorectal 
cancer [7]. In our opinion, data 
presented by Bakhoum et al. in this 
issue of Current Biology [1] and 
previously, demonstrating reduced 
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We agree with Bakhoum et al. [1] 
that whole chromosome instability 
involving intact chromosomes 
can be explained by mitotic 
errors. Importantly, changes in 
chromosome number between 
tumour cells are frequently 
accompanied by structural 
chromosomal alterations, often 
affecting the same chromosome [2,3] 
and multiple mechanisms linking 
the generation of structural and 
numerical aberrations have been 
identified [4]. Most researchers 
measure changes in chromosome 
numbers between tumour cells 
using centromeric fluorescence 
in situ hybridisation (FISH) [5], 
which cannot distinguish between 
aneuploidy of intact and structurally 
abnormal chromosomes. Limiting 
the definition of chromosomal 
instability (CIN) to whole, intact 
chromosomes is therefore unlikely 
to adequately reflect the complexity 
of solid tumour genomes and CIN. 
We therefore favour the broader 
definition of CIN as “losses and 
gains of whole chromosomes or 
large portions thereof” as described 
by the Vogelstein laboratory [6] and 
commonly used by others.
In their short correspondence, 
Bakhoum et al. [1] conclude that 
an increased frequency of lagging 
centric chromosomes is the most 
conspicuous difference between 
CIN+ and CIN- cells. We previously 
demonstrated that pre-mitotic 
defects, namely replication stress, 
underlie a high proportion of 
chromosome segregation errors in 
colorectal CIN+ cells [7]. We also 
observe a significantly (p < 0.05) 
higher median percentage of 
anaphases displaying acentrics 
and bridges in five CIN+ (17% 
and 18%, respectively) versus five 
CIN- (7% acentrics and 5% bridges) 
cell lines, confirming our original 
conclusion, and consistent with the 
established presence of acentrics 
in cancer cells [8,9]. The scarcity 
of acentrics detected in Bakhoum 
et al.’s analysis could therefore 
chromosome missegregation and 
deviation of centromere numbers 
upon suppression of mitotic defects, 
do not contradict the conclusions 
of our recent study [7], nor do they 
minimize the importance of DNA 
replication stress as a contributor to 
CIN in colorectal and other cancers 
[10]. In contrast, our observations, 
together with the data of Bakhoum 
et al., suggest multiple mechanisms 
likely contribute to CIN both within 
and between tumour types [4].
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